Such studies, together with the fact that administration of IL-10 can suppress collagen-induced arthritis [16], the diabetes of NOD [17] mice as well as experimental autoimmune encephalomyelitis [31], support the potential therapeutic use of band 3 peptides 241–251 and 282–296 in autoimmune hemolytic anemia. This evidence concerns the gene IL10 and arthritic joint disease.